SARS-CoV-2 メインプロテアゼと20Sプロテアソームの共性阻害体の絶対結合自由エネルギーの迅速かつ効果的な予測
Jiao Zhou1, Arjun Saha2, Ziwei Huang1,3,4
1Ciechanover Institute of Precision and Regenerative Medicine, School of Life and Health Sciences, Chinese University of Hong Kong, Shenzhen, 518172, China.
Journal of the American Chemical Society
|April 18, 2022
まとめ
新しい計算方法により,SARS-CoV-2 主要プロテアゼ (Mpro) および他の標的に対する薬の開発に不可欠な共性阻害剤の結合エネルギーを正確に予測できます.
科学分野:
- 生物化学
- コンピュータ化学
- 薬物の発見
背景:
- COVID-19 パンデミックは,SARS-CoV-2 Mproのようなウイルスプロテアスを標的とする有望な手段として,共性阻害剤が登場する新しい治療戦略を必要とします.
- 結合抑制剤は従来の薬よりも利点がありますが,結合 afinities,特に結合結合形成を正確に予測することは,計算モデルにとって課題です.
- 既存の計算方法では,共価結合形成の複雑な化学的性質を捉えることができず,効果的な阻害剤の設計を妨げています.
研究 の 目的:
- 結合抑制剤の絶対結合自由エネルギー (ABFE) を予測するための堅牢な計算方法を開発し,検証する.
- 量子力学と分子ダイナミクスを統合し,共振と非共振の両方の相互作用を正確にモデル化します.
- 信頼性の高い結合親和性予測を提供することで,新しい共性阻害剤の設計を加速する.
主な方法:
- 量子力学的計算によるタンパク質二極体ランゲヴィン二極体 (PDLD/S-LRA/β) の統合.
- 水性環境における阻害弾頭と標的アミノ酸の反応エネルギーの計算.
- SARS-CoV-2 Mproと20S プロテアソームを標的とした共性阻害剤のABFEを予測する方法の適用.
主要な成果:
- 開発された計算方法は,異なる弾頭であっても,共性阻害剤のABFEを確実に予測します.
- このアプローチは,共価相互作用と非共価相互作用の組み合わせをうまく捉えています.
- SARS-CoV-2 Mproおよび20S プロテアソーム阻害剤の正確なABFE予測が達成されました.
結論:
- 結合抑制剤の絶対結合自由エネルギーを予測するための堅牢な計算プロトコルが確立されています.
- この方法は,特にSARS-CoV-2 Mproの有効な共性阻害剤の合理的な設計のための強力なツールを提供します.
- このプロトコルは,標的型タンパク質分解戦略の開発にも役立ちます.
関連する概念動画
Protein-protein Interfaces
13.9K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.9K
The Equilibrium Binding Constant and Binding Strength
14.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.0K
Protein-Drug Binding: Mechanism and Kinetics
1.1K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.1K
Conserved Binding Sites
4.5K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.5K
Ligand Binding Sites
13.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.7K
Protein-Drug Binding: Determination Methods
328
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
328


